Cargando…
Shockwaves prevent from heart failure after acute myocardial ischaemia via RNA/protein complexes
Shock wave treatment (SWT) was shown to induce regeneration of ischaemic myocardium via Toll‐like receptor 3 (TLR3). The antimicrobial peptide LL37 gets released by mechanical stress and is known to form complexes with nucleic acids thus activating Toll‐like receptors. We suggested that SWT in the a...
Autores principales: | Tepeköylü, Can, Primessnig, Uwe, Pölzl, Leo, Graber, Michael, Lobenwein, Daniela, Nägele, Felix, Kirchmair, Elke, Pechriggl, Elisabeth, Grimm, Michael, Holfeld, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345685/ https://www.ncbi.nlm.nih.gov/pubmed/27995765 http://dx.doi.org/10.1111/jcmm.13021 |
Ejemplares similares
-
Shock Wave Therapy Improves Cardiac Function in a Model of Chronic Ischemic Heart Failure: Evidence for a Mechanism Involving VEGF Signaling and the Extracellular Matrix
por: Gollmann‐Tepeköylü, Can, et al.
Publicado: (2018) -
Cardiac Shockwave Therapy – A Novel Therapy for Ischemic Cardiomyopathy?
por: Graber, Michael, et al.
Publicado: (2022) -
Safety and efficacy of direct Cardiac Shockwave Therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial
por: Pölzl, Leo, et al.
Publicado: (2020) -
Defining a therapeutic range for regeneration of ischemic myocardium via shock waves
por: Pölzl, Leo, et al.
Publicado: (2021) -
Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial—an update
por: Nägele, Felix, et al.
Publicado: (2022)